
News|Videos|December 8, 2020
Further Testing Rivipansel and Its Implications Through the RESET Clinical Trial
Helen Thackray, MD, dives deeper into how the researchers tested rivipansel on the study participants and the implications compared to previous trials.
Advertisement
Pharmacy Times interviewed Helen Thackray, MD, on her presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses research into rivipansel for acute vaso-occlusive crisis in sickle cell disease and the RESET clinical trial. In this video, Thackray dives deeper into how the researchers tested rivipansel on the study participants and the implications compared to previous trials.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
2
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
3
Oral GLP-1 Orforglipron Is Approved for Obesity
4
Early Oral Antiviral Use Associated With Lower Risk of Post–COVID-19 Condition, Study Finds
5




































































































































